Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Julie A. Gilmore, PhD
JCP
Original Research
Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone
April 1, 2001
Bruce R. Basson
,
Bruce J. Kinon
,
Cindy C. Taylor
, et al
JCP
Original Research
Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia
February 2, 2001
Bruce J. Kinon
,
Bruce R. Basson
,
Julie A. Gilmore
, et al
JCP
Original Research
Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine
October 31, 2000
Bruce J. Kinon
,
Bruce R. Basson
,
Julie A. Gilmore
, et al
PCC
Original Research
The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone
August 1, 2000
John S. Kennedy
,
Frank P. Bymaster
,
Bruce R. Basson
, et al
